StethoMe has been awarded European CE certification for its wireless stethoscope device and the AI algorithms it uses to examine children’s lung and heart recordings.
StethoMe is the first intelligent wireless stethoscope for parents capable of detecting, classifying and analysing pathological sounds within children’s lungs using medical grade precision.
StethoMe empowers parents with a simple-to-use device and app which guides them through each examination. Results are shared directly with a doctor who then advises as to whether that child needs to visit a doctor or emergency room or can remain at home under close supervision. The result: peace of mind for parents and a reduced burden on healthcare professionals by reducing the amount of unnecessary GP or hospital visits.
StethoMe offers incomparably higher sound level and quality compared with other stethoscopes available on the market. In contrast to traditional stethoscopes, StethoMe enables auscultation of a patient’s lungs and heart and is able to analyse recordings for the lungs using sophisticated AI algorithms.
Examinations with a traditional stethoscope depend on the experience and parameters of the physician’s auditory system. Medically tested, StethoMe has shown to increase accuracy by up to 13%.
“There are two main issues facing primary care. Firstly, the high rate of misdiagnosis that occurs (cases of delayed, missed, and incorrect diagnosis are common – in the range of 10 per cent to 20 per cent and, secondly, the very high number of unnecessary visits (up to 70 per cent in the US). We are beginning to see AI affect the world we live in substantially and the healthcare sector is no different. This is why we created StethoMe – to help address these challenges” said Wojciech Radomski, CEO, StethoMe.
The company has already been awarded multiple awards and is supported by institutions including: Adam Mickiewicz University in Poznań, Poznań University of Medical Sciences, Children’s University Hospital in Lublin, Institute of Tuberculosis and Lung Diseases in Rabka-Zdrój and more. The product will be available to consumers within the end of this year.
Headquartered in Poland, StethoMe is a team of 24 people with a vast amount of experience in the field of healthcare, telemedicine, AI and business. To date, the company has raised $2m in investment.